United States · Series B startup
3 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Funding summaryUpdated 26 Oct 2026
$65Mraised across 3 rounds since 2018, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $3.1M sold, first sale Dec 2025
Versant Ventures
5AM Ventures
HealthCapReported by FinSMEs
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Versant Ventures
Janus Henderson Investors5AM VenturesHealthCapKarolinska Development ABRedmile Group/ Rock SpringsSectoral AssetMissing a round, or an investor who was in one? Tell us.
Aprea Therapeutics's investors include Versant Ventures, Janus Henderson Investors, 5AM Ventures, HealthCap and Karolinska Development AB, and 2 more on record.
Aprea Therapeutics has raised $65M across 3 rounds since 2018.
Aprea Therapeutics's most recent round, $3.1M, was in Dec 2025.
Aprea Therapeutics's largest round on record is $57M (Series C), in Nov 2018.
Aprea Therapeutics's first round on record, in Nov 2018, was backed by Versant Ventures, 5AM Ventures and HealthCap and 3 others.
Aprea Therapeutics's latest named round is a Series B, in Feb 2019.
Aprea Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
